NCT06370039

Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease

Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Adult Subjects With Moderate to Severe Dry Eye Disease

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 109 (actual)
• Sponsor: Invirsa, Inc. · Industry
• Sex: All
• Age: 18 Years – 74 Years
• Healthy volunteers: Not accepted

Summary

Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during 4-week repeat dosing in subjects with moderate to severe dry eye disease.

Conditions

• Dry Eye Disease

Interventions

Type	Name	Description
DRUG	INV-102	INV-102 Ophthalmic Solution
DRUG	Vehicle	Vehicle Ophthalmic Solution

Timeline

• Start date: 2024-03-27
• Primary completion: 2024-07-03
• Completion: 2024-07-03
• First posted: 2024-04-17
• Last updated: 2025-07-02

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study